(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium
Jimenez-Diaz, Maria Belen; Ebert, Daniel; Salinas, Yandira; Pradhan, Anupam; Lehane, Adele; Myrand-Lapierre, Marie-Eve; O'Loughlin, Kathleen; Shackleford, David; De Almeida, Mariana Justino; Carrillo, Angela; Clark, Julie; Dennis, Adelaide; Spillman, Natalie; Kirk, Kiaran
Drug discovery for malaria has been transformed in the last 5 years by the discovery of many new lead compounds identified by phenotypic screening. The process of developing these compounds as drug leads and studying the cellular responses they induce is
|Collections||ANU Research Publications|
|Source:||PNAS - Proceedings of the National Academy of Sciences of the United States of America|
|01_Jimenez-Diaz_(+)-SJ733,_a_clinical_2014.pdf||1.79 MB||Adobe PDF|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.